Aug 09, 2023 / 05:30PM GMT
Sumant Kulkarni - Canaccord Genuity Group Inc. - Moderator
Pleased to have Intra-Cellular Therapies here today with us. Chief Commercial Officer, Mark Neumann is here, as well as Juan Sanchez who knows everything about the company, he's here in the audience as well.
Intra-Cellular has had a really nice launch of CAPLYTA, first with schizophrenia, and then, a real driver of growth has been the bipolar-depression market. And you have a lot of cool stuff going on in terms of that -- extension of that product for a franchise or rounding out that franchise as well as a lot of other things in your pipeline that we don't talk about as much as often probably as we should. (technical difficulty) And we'll go straight into Q&A if you don't mind.
Questions and Answers:
Mark Neumann - Intra-Cellular Therapies, Inc. - EVP, Chief Commercial OfficerYeah, sure. First of all, I'd like to thank you for the invitation. It a pleasure to be hear to share with the audience offered products that we have at ITCI. If I could just mention some disclaimer before I
Trustpilot
